# Quoin Pharmaceuticals Ltd.: Form 8-K, filed Mar 11, 2026

- Company: [Quoin Pharmaceuticals Ltd.](/companies/qnrx.md) (CIK 1671502)
- Form: 8-K
- Filed: 2026-03-11
- Accepted by EDGAR: Mar 11, 2026, 16:30 ET
- Period: 2026-03-11
- Accession: 0001104659-26-026410
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671502/000110465926026410/tm268576d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671502/000110465926026410/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671502/000110465926026410/tm268576d1_8k.htm

Filed Mar 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-026410. Last ingested by Listed: Nov 6, 2026, 18:24 ET. No prices; not investment advice.